Interlaboratory evaluation of VITEK2 system and Sensititre YeastOnēfor antifungal susceptibility testing of yeasts isolated from blood cultures against four antifungal agents

New Microbiologica

Volumn 34, Issue 2, 2011, Pages 195-201

  Farina, Claudio ^a,b,i   Manso, Esther ^a,c   Andreoni, Stefano ^a,d   Conte, Marco ^a,e   Fazii, Paolo ^a,f   Lombardi, Gianluigi ^a,g   Sanna, Silvana ^a,h   Russello, Giuseppe ^b  

^a Associazione Microbiologi Clinici Italiani   (Italy)

^b Microbiology Institute   (Italy)

^c Biochemicaland Microbiology Laboratory   (Italy)

^d MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^e Laboratory of Microbiology   (Italy)

^f PO 'Ospedale Santo Spirito'   (Italy)

^g AO 'Niguarda Ca' Granda'   (Italy)

^h UNIVERSITY OF SASSARI   (Italy)

ⁱ AO 'Ospedale San Carlo Borromeo'   (Italy)

Author keywords

Agreement; Antifungal susceptibility testing; Yeast

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSIS; YEAST;

ANTIFUNGAL AGENTS; BLOOD; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; YEASTS;

CANDIDA;

EID: 79958743326     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ALEXANDER B.D., PFALLER M.A. (2006). Contemporary tools for the diagnosis and management of invasive mycoses. Clin. Infect. Dis. 43 (Suppl. 1), S15-S27.
2. AL SWEIH N., AHMAD S., KHAN Z.U., KHAN S., AND CHANDY R. (2005). Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses. 48, 347-351.
3. AVOLIO M., GROSSO S., BRUSCHETTA G., DE ROSA R., CAMPORESE A. (2009). Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne. New Microbiol. 32, 179-184.
4. CLINICAL AND LABORATORY STANDARDS INSTITUTE. (2008). Reference method for brodi dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. CLINICAL AND LABORATORY STANDARDS INSTITUTE. (2008). Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A3, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
6. CLINICAL AND LABORATORY STANDARDS INSTITUTE. (2010). M27-S3 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Third Informal Supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
7. CUENCA-ESTRELLA M., GOMEZ-LOPEZ A. IZQUIERDO A., BERNAL-MARTINEZ L., CUESTA I., BUITRAGO M.J., RODRIGUEZ-TUDELA J.L. (2010). Comparison of the Vitek 2 antifungal susceptibility system with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. J Clin Microbiol. 48, 1782-1786.
8. EUCAST. (2008) Antimicrobial for Candida infections. EUCAST clinical MIC breakpoints. EUCAST 2008-07-24 (v 2.0).
9. GAREY K.W., REYE M., PAI M.P., MINGO D.E., SUDA K.J., TURPIN R.S., AND BEARDEN D.T. (2006). Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43, 25-31.
10. MAGILL S.S., SHIELDS C., SEARS C.L., CHOTI M., AND MERZ W.O. (2006). Triazole-cross resistance among Candida spp.: occurrence among bloodstream isolates, and implication for antifungal therapy. J. Clin. Microbiol. 44, 529-535.
11. Mokaddas E.M., Al Sweih N.A., and Khan Z.U. (2007). Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. 7 Med Microbiol 56, 255-259.
12. MORRELL M., FRASER V.J., AND KOLLEF M.J. (2005). Delaying empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for mortality. Antimicrob. Agents Chemother. 49, 3640-3645.
13. PRALLER M.A., DIEKEMA D.J., PROCOP G.W., RINALDI M.G. (2007). Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. 7 Clin Microbiol. 45, 796-802.
14. PFALLER M.A., CASTANHEIRA M., MESER S.A., MOET G.J., JONES R.N. (2010). Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Microbiol Infect Dis. 68, 278-283.